Abstract
Background/Objective
Gastrostomy tube (G tube) is a commonly performed procedure for nutritional support. Current guidelines recommend discontinuation of dual antiplatelet therapy (DAPT) prior to G tube placement to reduce bleeding risk.
Aims
We aim to compare bleeding risk in single, dual and no antiplatelet therapy during G tube placement.
Methods
We searched PubMed, Embase, Cochrane, and Web of Sciences to include comparative studies evaluating single antiplatelet (aspirin, clopidogrel), dual antiplatelet (DAPT, aspirin and clopidogrel), and no antiplatelet therapy. Direct as well as network meta-analyses comparing these arms were performed. Risk Differences (RD) with confidence intervals were calculated.
Results
12 studies with 8471 patients were included. On direct meta-analysis, there was no significant difference noted between DAPT compared to Aspirin (RD 0.001 95% CI − 0.012 to 0.014, p = 0.87), Clopidogrel (RD 0.001 95% CI − 0.009 to 0.010, p = 0.92) or no antiplatelet group (RD 0.007 95% CI − 0.011 to 0.026, p = 0.44).
Results were consistent on network meta-analysis and no difference was noted in bleeding rates when comparing DAPT with Aspirin (RD 0.001, 95% CI − 0.007 to 0.01, p = 0.76), Clopidogrel (RD 0.001, 95% CI − 0.01 to 0.011, p = 0.90) and no antiplatelet group (RD 0.002, 95% CI − 0.007 to 0.012, p = 0.62).
Conclusion
There is no significant difference in bleeding risk between DAPT, single antiplatelet or no antiplatelet therapy on a population level. On an individual level, risk of ischemic events should be weighed against the risk of bleeding based on patient circumstances and risk profile. Our findings offer to provide additional data to make an informed decision between patients and physicians to make clinical decisions by assessing individual risks and benefits for optimal care of complex patients.
Similar content being viewed by others
Abbreviations
- G tube:
-
Gastrostomy tube (endoscopically or radiologically)
- PEG:
-
Percutaneous endoscopic gastrostomy
- DAPT:
-
Dual antiplatelet therapy
- GI:
-
Gasto-intestinal
- SAPT:
-
Single antiplatelet therapy
- RD:
-
Risk difference
- RIG:
-
Radiologically inserted G tube
- NACE:
-
Net adverse clinical events
- MACE:
-
Major adverse cardiovascular events
- CVA:
-
Cerebrovascular accident
References
Molina Villalba C, Vázquez Rodríguez J, Gallardo Sánchez F. Gastrostomía endoscópica percutánea. Indicaciones, cuidados y complicaciones. Medicina Clínica 2019;152:229–236.
Lucendo A, Sánchez-Casanueva T, Redondo O, Tenías J, Arias Á. Risk of bleeding in patients undergoing percutaneous endoscopic gastrotrostomy (PEG) tube insertion under antiplatelet therapy: a systematic review with a meta-analysis. Revista Española de Enfermedades Digestivas 2015;107:128–136.
Page M, Moher D, Bossuyt P, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;n160.
Nisbet R, Elder J, Miner G. Data Understanding and Preparation. Handbook of Statistical Analysis and Data Mining Applications, 2009: 49–75.
https://handbook-5-1.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm
https://training.cochrane.org/handbook/current/chapter-11#section-11-4-4
Thosani N, Rashtak S, Kannadath B et al. Bleeding risk and mortality associated with uninterrupted antithrombotic therapy during percutaneous endoscopic gastrostomy tube placement. Am J Gastroenterol 2021;116:1868–1875.
Tramel R, Sandow T, April D, Ramalingam V. Safety and feasibility of percutaneous gastrostomy placement in patients on antiplatelet therapy. Ochsner J 2021;21:158–162.
Eventscribe.net. 2022. ACG 2020 ePoster Hall. https://www.eventscribe.net/2020/ACGPosters/fsPopup.asp?efp=RE5YS1FTRkIxMTY4Nw&PosterID=298414&rnd=0.6197251&mode=posterinfo. Accessed 28 April 2022.
Haddad P, Kannadath B, Munjal A et al. Mo1321 peg tube can be successfully placed in patients on uninterrupted dual-antiplatelet therapy without any complications: time to change clinical practice. Gastrointest Endosc 2019;89:AB490.
Chandrala C, Badipatla K, Vupputuri A, Nayudu S, Chilimuri S. Mo1205 Bleeding complications associated with percutaneous endoscopic gastrostomy in the setting of antithrombotic agents. Gastrointest Endosc 2017;85:AB461–AB462.
Kannadath B, Khurana S, Bhandari B et al. Percutaneous Endoscopic Gastrostomy (PEG) tubes can be safely placed in geriatric patients on uninterrupted Dual Anti-Platelet Therapy (DAPT). Am J Gastroenterol 2022;112:S684.
Lee C, Im J, Kim J et al. Risk factors for complications and mortality of percutaneous endoscopic gastrostomy: a multicenter, retrospective study. Surg Endosc 2013;27:3806–3815.
Thosani N, Nevah M, Khanijow V et al. Sa1683 Bleeding risk associated with continuing antiplatelet therapy during PEG tube placement: should we throw caution to the wind? Gastrointest Endosc 2012;75:243.
Lozoya-González D, Pelaez-Luna M, Farca-Belsaguy A, Salceda-Otero J, Vazquéz-Ballesteros E. Percutaneous endoscopic gastrostomy complication rates and compliance with the american society for gastrointestinal endoscopy guidelines for the management of antithrombotic therapy. J Parenteral Enteral Nutr 2011;36:226–230.
Singh D, Laya A, Vaidya O, Ahmed S, Bonham A, Clarkston W. Risk of Bleeding After Percutaneous Endoscopic Gastrostomy (PEG). Dig Dis Sci 2011;57:973–980. https://doi.org/10.1007/s10620-011-1965-7.
Bal B, Karim A, Olden K. Percutaneous endoscopic gastrostomy placement: do we need to stop the antiplatelet therapy? Gastrointest Endosc 2011;73:AB226.
Ruthmann O, Seitz A, Richter S et al. Perkutane endoskopische Gastrostomie. Der Chirurg 2009;81:247–254.
Schrag S, Sharma R, Jaik N et al. Complications related to Percutaneous Endoscopic Gastrostomy (PEG) tubes. A comprehensive clinical review. J Gastrointest Liver Dis 2007;16:407–418.
Funding
No funding was received for the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Research involving human and animal rights
No human subjects/animals were involved in this systematic review and meta-analysis.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
An editorial commenting on this article is available at https://doi.org/10.1007/s10620-023-07878-5.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gangwani, M.K., Aziz, M., Aziz, A. et al. Dual Antiplatelet Therapy Does Not Increase Bleeding Risk in Percutaneous Gastrostomy Tube Placement: Network Meta-Analysis. Dig Dis Sci 68, 1966–1974 (2023). https://doi.org/10.1007/s10620-022-07804-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-022-07804-1